SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 02/12/2020 | 3. Issuer Name and Ticker or Trading Symbol Verisk Analytics, Inc. [ VRSK ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 19,677(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option(2) | (3) | 12/14/2022 | Common Stock | 3,204 | 48.84 | D | |
Stock Option(2) | (3) | 04/01/2023 | Common Stock | 9,453 | 61.14 | D | |
Stock Option(4) | (3) | 04/01/2024 | Common Stock | 13,679 | 59.74 | D | |
Stock Option(4) | (3) | 04/01/2025 | Common Stock | 11,004 | 71.53 | D | |
Stock Option(4) | (5) | 04/01/2026 | Common Stock | 13,038 | 80.19 | D | |
Stock Option(4) | (6) | 04/01/2027 | Common Stock | 14,516 | 81.14 | D | |
Stock Option(4) | (7) | 04/01/2028 | Common Stock | 16,496 | 104 | D | |
Stock Option(4) | (8) | 07/01/2028 | Common Stock | 11,295 | 107.64 | D | |
Stock Option(4) | (9) | 04/01/2029 | Common Stock | 15,619 | 134.24 | D | |
Stock Option(4) | (10) | 01/15/2030 | Common Stock | 15,541 | 158.65 | D |
Explanation of Responses: |
1. This amount includes 11,570 restricted shares of Common Stock that were granted under the Issuer's 2013 Equity Incentive Plan. Subject to the terms of the Issuer's 2013 Equity Incentive Plan and the applicable award agreements thereunder, these restricted shares vest in four equal installments on the first, second, third and fourth anniversaries of their respective grant dates. |
2. Stock Options outstanding under the Issuer's 2009 Equity Incentive Plan. |
3. Immediately. |
4. Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan. |
5. 9,778 shares of Common Stock underlying this Stock Option are immediately, exercisable. The remaining 3,260 shares will become exercisable on 4/1/2020. |
6. 7,258 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 7,258 shares will become exercisable as follows: 3,629 shares on 4/1/2020, and 3,629 shares on 4/1/2021. |
7. 4,124 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 12,372 shares will become exercisable as follows: 4,124 shares on 4/1/2020, 4,124 shares on 4/1/2021, and 4,124 shares on 4/1/2022. |
8. 2,823 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 8,472 shares will become exercisable as follows: 2,824 shares on 7/1/2020, 2,824 shares on 7/1/2021, and 2,824 shares on 7/1/2022. |
9. The 15,619 shares of Common Stock underlying this Stock Option will become exercisable as follows: 3,904 shares on 4/1/2020, 3,905 shares on 4/1/2021, 3,905 shares on 4/1/2022, and 3,905 shares on 4/1/2023. |
10. The 15,541 shares of Common Stock underlying this Stock Option will become exercisable as follows: 3,885 shares on 1/15/2021, 3,885 shares on 1/15/2022, 3,885 shares on 1/15/2023, and 3,885 shares on 1/15/2024. |
Remarks: |
/s/ Kenneth E. Thompson, Attorney-in-fact | 02/20/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |